Current Size: 100%

Seminar Lectures 2021


Invited Speakers:

PD Dr. Gregor Hörmann, PhD (September 3rd, 2021)

A concluding highlight of our seminar series for the year 2021 was the on-site talk of PD Dr. Gregor Hörmann PhD. We were particularly happy to welcome Dr. Hörmann, a former member of the LBI HO, in person. Dr. Hörmann recently transferred to the Munich Leukemia Laboratory (MLL), where one of his focusses is the implementation of artificial intelligence (AI) into the daily diagnostic routine. His talk, with the title “Artificial Intelligence in Hematological Diagnosis”, gave an impression of state-of-the-art use of AI in the MLL, as well as an outlook on future developments in the field.


Dr. Patrick Haider (July 9th, 2021)

Dr. Patrick Haider, who is currently a PhD student in the group of Univ. Prof. Dr. Johann Wojta at the Medical University of Vienna, Department of Internal Medicine II, shared some of his current research findings in a lecture entitled “Interleukin-4 receptor alpha signaling regulates monocyte homeostasis”. The webinar mode was continued.


Univ.-Prof. DDr. Thomas Lion (July 2nd, 2021)

We were pleased to welcome Univ.-Prof. DDr. Thomas Lion, who is heading up the Molecular Microbiology research group at the St. Anna Kinderkrebsforschung/CCRI in Vienna, as a guest speaker. The subject of Univ.-Prof. DDr. Lion’s lecture was particularly topical as he talked about “Adeno-Virus and Corona-Virus Infections: Laboratory Investigations and Clinical Challenges”. Due to COVID-19-related safety measures the seminar was held again as a webinar via Zoom.


Univ.-Prof. DI Dr. Richard Moriggl (May 21st, 2021)

It was with great pleasure that we re-launched our seminar lectures after the COVID-19 pandemic-related pause. Our first guest speaker in 2021 was Univ.-Prof. DI Dr. Richard Moriggl, who is heading the Functional Cancer Genomics, Animal Breeding and Genetics Unit at the University of Veterinary Medicine Vienna. His lecture on the topic of “Novel STAT-Drivers und Novel STAT-Inhibitors in Hematologic and Oncologic Disorders” was eagerly anticipated and equally lauded. Due to the current COVID-19-related restrictions, the seminar was held as a webinar via Zoom.